Home
/
Profound Medical Corp.
/
Financials
/
Quarterly
Profound Medical Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Profound Medical Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.29M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$2.21M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$2.62M
May 8, 2025
Q3
2025
Sep 30, 2024
$2.83M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$2.23M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$1.44M
May 8, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.06M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$1.98M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$2.34M
May 8, 2025
Q3
2025
Sep 30, 2024
$2.54M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$1.95M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$1.22M
May 8, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.98M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($15.70M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($15.70M)
Nov 13, 2025
Q3
2025
Mar 31, 2025
($10.72M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($10.72M)
May 8, 2025
Q2
2025
Mar 31, 2025
($10.72M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($9.37M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($6.92M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($6.92M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($6.59M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($6.59M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($6.59M)
May 8, 2025
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.91M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($13.81M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($11.17M)
May 8, 2025
Q3
2025
Sep 30, 2024
($9.00M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($7.84M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($7.88M)
May 8, 2025